Chikungunya Virus Infection
📧 Sign up to get email alerts when something new happens for Chikungunya Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Results: A Phase 2 Clinical Trial of VLA1553 in Healthy Children Aged 1 to 11 Years [Phase 2]
Phase 2 clinical trial results of VLA1553 in healthy children aged 1 to 11 years have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Xpert® Tropical Fever Test on GeneXpert® Edge X System
A clinical trial update indicates Cepheid is enrolling by invitation to evaluate the Xpert Tropical Fever Test on the GeneXpert Edge X Syste…
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553) [Phase 3]
This clinical trial update reports on antibody persistence and long-term safety data from a Phase 3 chikungunya vaccine study (VLA1553).
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: Phase 1 Study of SAR440894 vs Placebo [Phase 1]
The Phase 1 trial of SAR440894 versus placebo in chikungunya virus infection has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: A Phase 2 Clinical Trial of VLA1553 in Healthy Children Aged 1 to 11 Years [Phase 2]
A Phase 2 trial of the chikungunya vaccine VLA1553 in healthy children aged 1 to 11 years has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Long-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster Vaccination [Phase 3]
An update on a Phase 3 long-term follow-up trial evaluating the safety and immunogenicity of PXVX0317 as a single-dose or booster vaccinatio…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults [Phase 3]
Phase 3 trial updating on consistency across three lots of a live-attenuated chikungunya vaccine in healthy adults; study completed with res…
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: A Study to Assess the Safety and Immunogenicity of PXVX0317 Chikungunya Virus Virus-Like Particle Vaccine [Phase 2]
A Phase 2 study assessing safety and immunogenicity of PXVX0317 Chikungunya virus-like particle vaccine has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-07-25Clinical Trial Update: Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults [Phase 3]
A Phase 3 pivotal study evaluating safety and immunogenicity of a live-attenuated Chikungunya virus vaccine in adults has completed with res…
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: Chikungunya Vaccine (V184) Study in Previously Exposed Adults (V184-006) [Phase 2]
Phase 2 clinical trial update for the Chikungunya vaccine V184 in adults previously exposed to the virus; study completed with results poste…
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults [Phase 2]
Phase 2 trial update of the chikungunya vaccine PXVX0317 CHIKV-VLP in healthy adults has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-20Clinical Trial Update: Safety, Tolerability and Long-term Immunogenicity of Different Formulations of a Chikungunya Vaccine (V184-005) [Phase 2]
Phase 2 clinical trial update evaluating safety, tolerability, and long-term immunogenicity of different formulations of a Chikungunya vacci…
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine [Phase 2]
A Phase II study assessing safety and immunogenicity of a chikungunya vaccine has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-05-14Clinical Trial Update: Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults [Phase 2]
Phase 2 trial assessing safety and immunogenicity of the Chikungunya vaccine VRC-CHKVLP059-00-VP in healthy adults has completed with result…
-
CLINICAL_TRIALS trial_result · 2016-07-26Clinical Trial Update: Seroprevalence of Chikungunya at the End of the First Chikungunya Outbreak in the French Antilles Within a Sample of Patients Treated for a HIV Infection
A completed clinical trial from Martinique reports the seroprevalence of chikungunya virus infection among patients treated for HIV infectio…
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: Chikungunya Virus Vaccine Trial in Healthy Adults [Phase 1]
Phase 1 clinical trial of a chikungunya virus vaccine in healthy adults completed, with results posted in 2016.